Host Committee

Chairman

Francois Nader, M.D.
President and Chief Executive Officer
NPS Pharmaceuticals, Inc.

Immediate Past Chair

Sol J. Barer, Ph.D.
Former Chairman
Celgene Corporation

President and CEO

Debbie Hart
President and CEO
BioNJ

Vice Chairman

Christopher J. Schaber, Ph.D.
President and Chief Executive Officer
Soligenix, Inc.

Secretary

Donna Tempel, Ph.D., MBA
President and Chief Executive Officer
Drais Pharmaceuticals Inc.

Treasurer

Elizabeth G. Posillico, Ph.D.
President and Chief Executive Officer
Elusys Therapeutics, Inc.

Board Members

Al Altomari
President and Chief Executive Officer
Agile Therapeutics

Marc Bonnefoi, DVM, Ph.D.
Head, North America R&D Hub and Global Head, Drug Disposition, Preclinical Safety and Animal Research
Sanofi

John F. Crowley
Chairman and Chief Executive Officer
Amicus Therapeutics, Inc.

Pamela M. Demain, MBA, CLP
Executive Director, Transactions, Business Development and Licensing
Merck & Co., Inc.

Christian Kopfli, Esq.
Chief Executive Officer
Chromocell Corporation

Will Lewis
President and Chief Executive Officer
Insmed Incorporated

John Maki
President and Chief Executive Officer
Vicus Therapeutics

Anthony S. Marucci, MBA
Founder, President, Chief Executive Officer and Director
Celldex Therapeutics, Inc.

David Pearson
President and Global Head of Corporate Development
ThromboGenics, Inc.

Stuart W. Peltz, Ph.D.
Chief Executive Officer
PTC Therapeutics, Inc.

Spiro Rombotis
President and Chief Executive Officer
Cyclacel Pharmaceuticals, Inc.

Alan L. Rubino
Chief Executive Officer
Emisphere Technologies, Inc.

Shawn Tomasello
Senior Vice President
Celgene Corporation